HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Dae Kim Selected Research

Percutaneous Coronary Intervention

7/2022The Busan Regional CardioCerebroVascular Center Project's Experience Over a Decade in the Treatment of ST-segment Elevation Myocardial Infarction.
2/2018Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI.
1/2018Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial.
9/2015Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.
4/2015Clinical utility of new bleeding criteria: a prospective study of evaluation for the Bleeding Academic Research Consortium definition of bleeding in patients undergoing percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Dae Kim Research Topics

Disease

5Myocardial Infarction
07/2022 - 11/2011
5Hemorrhage
04/2022 - 10/2006
4Acute Coronary Syndrome
01/2020 - 09/2015
4Hypertension (High Blood Pressure)
10/2016 - 09/2007
3Inflammation (Inflammations)
01/2020 - 07/2011
3Thrombosis (Thrombus)
09/2015 - 07/2008
3Essential Hypertension
12/2010 - 09/2007
2ST Elevation Myocardial Infarction
07/2022 - 02/2018
2Neoplasms (Cancer)
01/2020 - 01/2019
2Fibrosis (Cirrhosis)
11/2016 - 01/2008
2Coronary Artery Disease (Coronary Atherosclerosis)
09/2015 - 05/2014
2Dyspnea (Shortness of Breath)
02/2011 - 09/2007
1Liver Cirrhosis (Hepatic Cirrhosis)
04/2022
1Mucolipidoses (Sialidosis)
04/2021
1Hypoxia (Hypoxemia)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Colitis
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Atrial Fibrillation
11/2018
1Cardiogenic Shock
02/2018
1Heart Failure
02/2018
1Immune System Diseases (Immune Disorders)
01/2017
1Hypercholesterolemia
10/2016
1Hyperlipidemias (Hyperlipidemia)
10/2016
1Kidney Neoplasms (Kidney Cancer)
11/2015
1Stroke (Strokes)
09/2015
1AIDS-Related Complex (ARC)
09/2015
1Leukemia
10/2014
1Brain Ischemia (Cerebral Ischemia)
03/2013
1Pain (Aches)
01/2013
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2013
1Bone Resorption
01/2012
1Ventricular Remodeling
11/2011
1Infarction (Infarctions)
11/2011
1Left Ventricular Dysfunction
11/2011
1Obesity
07/2011
1Asthma (Bronchial Asthma)
07/2011
1Pulmonary Embolism
02/2011
1Pleural Effusion (Pleural Effusions)
02/2011
1Type 2 Diabetes Mellitus (MODY)
12/2010
1Atopic Dermatitis (Atopic Eczema)
10/2009
1Ulcer
09/2009
1Wound Infection (Wound Infections)
02/2009
1Venous Thrombosis (Deep-Vein Thrombosis)
07/2008

Drug/Important Bio-Agent (IBA)

4Clopidogrel (Plavix)FDA Link
01/2020 - 03/2013
3TicagrelorIBA
01/2020 - 01/2018
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2018 - 06/2009
2Valsartan (Vals)FDA Link
01/2018 - 11/2011
2Angiotensin Receptor AntagonistsIBA
01/2018 - 11/2011
2Antihypertensive Agents (Antihypertensives)IBA
10/2016 - 09/2007
2Proteins (Proteins, Gene)FDA Link
10/2014 - 01/2008
2salicylhydroxamic acid (SHAM)IBA
01/2013 - 01/2013
1Fatty Acids (Saturated Fatty Acids)IBA
04/2022
1Sirolimus (Rapamycin)FDA Link
04/2021
1Neuraminidase (Sialidase)IBA
04/2021
1CytokinesIBA
01/2020
1Prolyl-Hydroxylase InhibitorsIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Histone Deacetylase InhibitorsIBA
01/2020
1AmmoniaIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1Anti-Arrhythmia AgentsIBA
02/2018
1Interleukin-2 (IL2)IBA
01/2017
1CholesterolIBA
10/2016
1Coloring Agents (Dyes)IBA
10/2016
1IrbesartanFDA LinkGeneric
10/2016
1Atorvastatin (Lipitor)FDA Link
10/2016
1ReninIBA
11/2015
1PolymersIBA
09/2015
1BESIBA
09/2015
1Prasugrel HydrochlorideFDA Link
09/2015
1RNA Splicing FactorsIBA
10/2014
1TroponinIBA
05/2014
1AntioxidantsIBA
01/2012
1AcidsIBA
01/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2011
1LeptinIBA
07/2011
1Hormones (Hormone)IBA
07/2011
1AdiponectinIBA
07/2011
1AdipokinesIBA
07/2011
1Warfarin (Coumadin)FDA LinkGeneric
02/2011
1lacidipineIBA
12/2010
1Phorbol EstersIBA
10/2009
1eupatilinIBA
09/2009
1Losartan (Cozaar)FDA LinkGeneric
06/2009
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
06/2009
1DNA (Deoxyribonucleic Acid)IBA
10/2008

Therapy/Procedure

10Therapeutics
07/2022 - 02/2008
5Percutaneous Coronary Intervention
07/2022 - 04/2015
4Stents
01/2020 - 03/2013
1Enteral Nutrition (Feeding, Tube)
04/2022
1Parenteral Nutrition
04/2022
1Length of Stay
04/2022
1Immunotherapy
01/2020
1Drug Therapy (Chemotherapy)
01/2019
1Electric Countershock (Cardioversion)
11/2018
1Drug-Eluting Stents
09/2015
1Myocardial Revascularization
02/2009